-transparent.png){kind=logo}
Upon hospital admission a patient was found to have severe anemia and a strongly positive direct antiglobulin test (DAT). The patient was taking probenecid periodically for gout. An antibody was detected in the patient's serum that only reacted with red blood cells (RBCs) when probenecid was added. Eluates from the patient's RBCs, with and without the presence of drug, were nonreactive. Upon the discontinuation of probenecid, the patient's hemoglobin level improved steadily. We believe this to be the first reported case of immune hemolytic anemia associated with probenecid.
Related Publications
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
February 1986,
The Journal of rheumatology,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
January 1997,
Transfusion,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
August 1986,
Archives of internal medicine,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
August 1985,
Archives of internal medicine,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
January 2004,
Transfusion,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
November 1978,
Southern medical journal,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
January 2010,
Blood reviews,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
June 1987,
Clinical pharmacy,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
February 2009,
Praxis,
S D Sosler, and
O Behzad, and
G Garratty, and
C L Lee, and
N Postoway, and
O Khomo
January 1990,
Vox sanguinis,
